Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s based on the book Make Better Decisions, which distills insights…
The post Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition appeared first on DrugPatentWatch – Make Better Decisions.
